|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 11400 TOMAHAWK CREEK PARKWAY |
Address2 | |
City | LEAWOOD |
State | KS |
Zip Code | 66211 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 1342-12
|
||||||||
|
6. House ID# 321800000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Thomas A. Robinett, Jr., General Counsel |
Date | 12/07/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S3295, Department of Labor Appropriations Act, 2013, Support increased FY13 spending on Title VII Sec 747 primary care training grants.
No Bill Number, Medicare physician payment reform of the Sustainable Growth Rate, Medicare physician pay cuts scheduled for 2013.
No Bill Number, Oppose repeal of subsidies for health insurance exchanges.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health Resources & Services Administration (HRSA),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa M. |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin J. |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
HR2119, Ryan Creedon Act, Opposing a requirement that physicians be specifically trained on the dangers of addictive drugs.
HR3667, Primary Care Workforce Access Improvement Act of 2011, GME modernization pilot program authorization and funding for non-hospital training sites.
S3295, Department of Labor Appropriations Act, 2013, Support increased FY13 spending on Title VII Sec 747 primary care training grants.
S507, Prescription Drug Abuse Prevention and Treatment Act, funding for state monitoring of prescription drug use.
No Bill Number, Labor HHS Appropriations Bill, Support for funding Health Professions grants program and funding for HRSA and AHRQ.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health Resources & Services Administration (HRSA),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa M. |
Baker |
|
House Legislative Assistant, Analyst, and Dire |
|
Kevin J. |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR2119, Ryan Creedon Act, Opposing a requirement that physicians be specifically trained on the dangers of addictive drugs.
HR3630, Welfare Integrity and Data Improvement Act, Ten month extension of Medicare physician fee schedule.
HR3667, Primary Care Workforce Access Improvement Act of 2011, GME modernization pilot program authorization and funding for non-hospital training sites.
HR5, Medical liability reform and IPAB repeal Protecting Access to Healthcare Act, Medical liability reform.
HR452, Medicare Decision Accountability Act, Revamping the Independent Payment Advisory Board.
HR5707, Medicare Physician Payment Innovation Act of 2012, Replace Medicare physician payment's SGR with higher payment rates for primary care.
HR5888, Physician Reentry Demonstration Program Act, Revise bill so sub-specialists do not reenter practice as primary care docs in CHCs, VA clinics and school based centers.
S3187, Synthetic Drug Abuse Prevention Act of 2012, discussion on Opioid abuse and pain management as part of PDUFA reauthorization. Support appropriate prescription drug monitoring which is not burdensome to family physicians.
S3295, Department of Labor Appropriations Act 2013, Support increased appropriations for Agency for Healthcare Research and Quality in FY2013, AHRQ funding budget priority, Support increased FY13 spending on Title VII Sec 747 primary care training grants.
No Bill Number, FDA/CDER meeting on chronic pain management, Effective pain management.
No Bill Number, 2013 Family Physician of the Year competition judge.
No Bill Number, Protect access to healthcare act, Medical liability reform.
No Bill Number, Medicare physician payment reform of the Sustainable Growth Rate, Medicare physician pay cuts scheduled for 2013.
No Bill Number, Increasing physician awareness of TBI and PTSD, Promoting family physician ability to assist with these conditions.
No Bill Number, Comprehensive Primary Care, Medical Home and Healthcare Reform.
No Bill Number, PCPCC Center for Consumer Engagement, Medical Home and Health Care Reform.
No Bill Number, Tobacco cessation, Health of the public.
No Bill Number, Primary care meeting, Medical Home and Health Care Reform.
No Bill Number, Meaningful Use meetings, Medical Home and Health Care Reform.
No Bill Number, Electronic Health Records, Ensuring payments for true primary care physicians.
No Bill Number, 2013 proposed inpatient PPS, Supporting GME slots for primary care.
No Bill Number, Valuation of Primary Care, strategies for improving primary care payment in the physician fee schedule.
No Bill Number, Primary care incentive payment PCIP, Re-question CMS release data on PCIP use.
No Bill Number, National Priorities and Research Agenda, PCORI should focus research on more common medical conditions first.
No Bill Number, National School lunch program, Improve school nutrition programs accessed through state education by providing incentives for school nutrition providers to replace foods with little or no nutritional value.
No Bill Number, Oppose repeal of subsidies for health insurance exchanges.
No Bill Number, Medicare physician fee schedule for 2013, Support for short term payment reforms to allow primary care access to non face to face codes.
No Bill Number, Comprehensive Primary Care Initiative, Promote the CPCI to family physician practices in the seven geographic markets.
No Bill Number, Medicaid payments to primary care physicians, Oppose expansion of definition of physicians who are eligible for primary care Medicaid support.
No Bill Number, White House meeting on improving health care coordination and quality. Support for Patient Centered Medical Home as a health care delivery model to improve coordination of care.
No Bill Number, White House meeting on implementation of meaningful use of HIT, Support for standards of interoperability of HIT systems.
No Bill Number, Adequacy and accuracy of Medicare physician payment, Positive payment differential for primary care physicians.
No Bill Number, Patient Centered Medical Home, Increasing support for the concept in discussing delivery system reform.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), White House Office, Agency for Health Care Policy & Research, Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Agriculture - Dept of (USDA),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa M. |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Kevin J. |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Robert |
Bennett |
|
|
|
Jerome |
Connolly |
|
|
|
Mark |
Cribben |
|
|
|
Deborah |
Weiner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
HR 5, Protecting Access to Health Care Act, Capping medical liability.
No Bill Number, Oppose repeal of subsidies for health insurance exchanges.
No Bill Number, Comprehensive Primary Care Initiative, Promote the CPCI to family physician practices in seven geographic markets.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin J. |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
S507, Prescription Drug Abuse Prevention and Treatment Act, funding for state monitoring of prescription drug use.
No Bill Number, Labor HHS Appropriations Bill, Support for funding Health Professions grants program and funding for HRSA and AHRQ.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa M. |
Baker |
|
House Legislative Assistant, Analyst, and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR5, Protecting Access to Health Are Act, Capping medical liability.
HR452, Medicare Decisions Accountability Act, Revamping the independent payment advisory board.
HR3630, Welfare Integrity and Data Improvement Act, Ten month extension of Medicare physician fee schedule.
HR3667, Primary Care Workforce Access Improvement Act of 2011, GME modernization pilot program authorization, Direct GME funding for non-hospital training sites.
HR 4013, Temporary Payroll Tax Cut Continuation Act, ten month extension of the Medicare physician fee schedule.
HR5707, Medicare Physician Payment Innovation Act of 2012, Replace Medicare physician payment's SGR with higher payment rates for primary care.
No Bill Number, Valuation of Primary Care, strategies for improving primary care payment in the physician fee schedule.
No Bill Number, Primary care incentive payment PCIP, Re-question CMS release data on PCIP use.
No Bill Number, Medicaid payments to primary care physicians, Oppose expansion of definition of physicians who are eligible for primary care Medicaid support.
No Bill Number, Medicare physician payment reform of the Sustainable Growth Rate, Medicare physician pay cuts scheduled for 2013.
No Bill Number, Increasing physician awareness of TBI and PTSD, Promoting family physician ability to assist with these conditions.
No Bill Number, Comprehensive Primary Care, Medical Home and Healthcare Reform.
No Bill Number, PCPCC Center for Consumer Engagement, Medical Home and Health Care Reform.
No Bill Number, Tobacco cessation, Health of the public.
No Bill Number, Primary care meeting, Medical Home and Health Care Reform.
No Bill Number, Meaningful Use meetings, Medical Home and Health Care Reform.
No Bill Number, Electronic Health Records, Ensuring payments for true primary care physicians.
No Bill Number, 2013 proposed inpatient PPS, Supporting GME slots for primary care.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS), White House Office,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa M. |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin J. |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Mark |
Cribben |
|
|
|
Deborah |
Weiner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
No Bill Number, Proposal to create "Special medical use" category of prescription drugs, Should FDA create category of drugs that non physicians like pharmacists could prescribe.
No Bill Number, National Priorities and Research Agenda, PCORI should focus research on more common medical conditions first.
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin J. |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
HR5, Medical liability reform and IPAB repeal Protecting Access to Healthcare Act, Medical liability reform.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa M. |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
No Bill Number, Preventing tobacco use among youth, Enhancing the efforts to prevent young people from using tobacco products.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin J. |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
No Bill Number, Proposal to create "Special medical use" category of prescription drugs, Should FDA create category of drugs that non physicians like pharmacists could prescribe.
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin J. |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
No Bill Number, National School lunch program, Improve school nutrition programs accessed through state education by providing incentives for school nutrition providers to replace foods with little or no nutritional value.
17. House(s) of Congress and Federal agencies Check if None
Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin J. |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |